Novo Holdings, the investment company that controls Novo Nordisk and holds the wealth of the Novo Nordisk Foundation, is backing a fund aimed at Italian drug startups, according to Bloomberg. The move extends a pattern that has seen the Danish investor push capital into life sciences hubs well outside Copenhagen, including European deep-tech vehicles backed alongside the […]

This story continues at The Next Web